ACRS Q2 2018 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

Q2 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$4M

Gross Profit

$2M67.9% margin

Operating Income

-$32M-869.9% margin

Net Income

-$31M-849.2% margin

EPS (Diluted)

$-1.01

QoQ Revenue Growth

+228.8%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$202M

Total Liabilities

$28M

Stockholders' Equity

$174M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$0	—
Gross Profit	$2M	$0	—
Operating Income	-$32M	-$15M	-109.1%
Net Income	-$31M	-$15M	-110.4%

Revenue Segments

Product

$2M42%

Laboratory Research Revenue

$1M31%

Other Revenue

$1M27%